Cane Capital Partners’s Humana HUM Stock Holding History

Cane Capital Partners’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,299	Closed	-$225K	–	146
2026 Q1	$225K	Buy	+1,299	New	+$266K	0.1%	108

Other funds holding HUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Eagle Capital Management (New York) New York $32.7B AUM 17.15% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cane Capital Partners's HUM Position: Q2 2026 in Review

Cane Capital Partners sold out of Humana (HUM) in Q2 2026, closing a stake of 1,299 shares — an estimated $225K sold.

Cane Capital Partners first reported a position in HUM in Q1 2026 and held it in 1 quarter. The position peaked at $225K in Q1 2026. 919 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

Cane Capital Partners reported no remaining Humana position as of Q2 2026 after selling out during the quarter.
Cane Capital Partners sold 1,299 Humana shares in Q2 2026, an estimated $225K.
Cane Capital Partners first reported a position in Humana in Q1 2026 and held it in 1 quarter.
Cane Capital Partners's Humana position peaked at $225K in Q1 2026.
919 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Cane Capital Partners's 13F filing for Q2 2026, filed 5 Aug 2026.